CL
Colgate-Palmolive Company
Colgate-Palmolive Company historical holders
total: 12
AKO Capital Colgate-Palmolive Company transactions over time
- Total transactions:
- 9
- New positions:
- 1
- Sold out:
- 1
- Added:
- 5
- Reduced:
- 2
- Held since:
- 2016 Q4
- Held for:
- 8 quarters
- Latest activity:
- 2018 Q4
Nicolai Tangen has been an institutional investor in Colgate-Palmolive Company (CL) since 2016 Q4. According to 2026 Q1 report, Nicolai Tangen doesn't hold any shares. The fund/company first acquired CL in 2016 Q4, initially purchasing 583,223 shares. Since the initial investment, AKO Capital has made 8 more transactions in this position.
When did Nicolai Tangen exit their CL position?
Nicolai Tangen no longer holds Colgate-Palmolive Company (CL). They sold off their entire position in 2018 Q4, closing out an investment that began in 2016 Q4.
When did Nicolai Tangen first invest in CL?
Nicolai Tangen first invested in Colgate-Palmolive Company (CL) in 2016 Q4 at the reported quarter-end price of $65.44 per share, acquiring 583,223 shares in their initial purchase.
What is Nicolai Tangen's average cost basis for CL?
Based on historical transaction data, Nicolai Tangen's estimated cost basis for Colgate-Palmolive Company (CL) is approximately $67.19 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $67.19
- Weighted AVG sell price:
- $67.47
CL transactions history by AKO Capital
9 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2018 Q4
|
0.00%
|
$66.95
|
-100% (-879,383)
|
|||
|
2018 Q3
|
3.00%
|
$66.95
|
+16.59% (+125,124)
|
|||
|
2018 Q2
|
2.64%
|
$64.81
|
+9.10% (+62,927)
|
|||
|
2018 Q1
|
2.93%
|
$71.68
|
+13.82% (+83,960)
|
|||
|
2017 Q4
|
3.56%
|
$75.45
|
+17.92% (+92,292)
|
|||
|
2017 Q3
|
3.08%
|
$72.85
|
+2.29% (+11,512)
|
|||
|
2017 Q2
|
3.31%
|
$74.13
|
-0.63% (-3,208)
|
|||
|
2017 Q1
|
3.33%
|
$73.19
|
-13.11% (-76,447)
|
|||
|
2016 Q4
|
4.90%
|
$65.44
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.